top of page
actym posterboard hero ellen.jpg

News & Events

flowsaber_a_minimal_abstract_translucent_chemical_pattern_desig_4935fa70-cd4a-4c02-9652-32

February 17, 2022

Actym Therapeutics CEO Dr. Christopher Thanos named one of the “Top 25 Biotech CEOs of 2022”

February 14, 2022

Actym Therapeutics Announces Issuance of US Patent

November 12, 2021

Actym Therapeutics Announces Lead Candidate for Clinical Development, Presentation at SITC

November 11, 2021

Actym Therapeutics, Inc. today announced the appointment of Chan Whiting, Ph.D. as Chief Development Officer

Jun 2, 2025

Actym Therapeutics Announces Issuance of US Patents

actym footer final.jpg
bottom of page